[6], [7] Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent chronic liver disorder worldwide, with an increasing incidence driven by the global rise in obesity and metabolic syndrome
Due to promising research, Wegovy was recently approved by the Food and Drug Administration (FDA) for use in reducing the risk of heart attacks and strokes in people with a higher risk of these events
GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in your gut that plays a key role in regulating blood sugar and appetite
The REWIND trial, targeting cardiovascular events in T2DM participants without previous cardiovascular history, found that dulaglutide reduced cardiovascular outcomes, and was well tolerated [61]
Clinical Oversight & Safety Clinical services provided through Beluga Health (led by Dr
Below are some of the most commonly asked questions about this unique class of prescription drugs
